These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 25343826

  • 1. Rationale of mesenchymal stem cell therapy in kidney injury.
    Fleig SV, Humphreys BD.
    Nephron Clin Pract; 2014; 127(1-4):75-80. PubMed ID: 25343826
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury.
    Tögel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C.
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1626-35. PubMed ID: 17213465
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mesenchymal Stem Cells in Kidney Repair.
    Morigi M, Rota C, Remuzzi G.
    Methods Mol Biol; 2016 May; 1416():89-107. PubMed ID: 27236667
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion.
    Erpicum P, Detry O, Weekers L, Bonvoisin C, Lechanteur C, Briquet A, Beguin Y, Krzesinski JM, Jouret F.
    Nephrol Dial Transplant; 2014 Aug; 29(8):1487-93. PubMed ID: 24516234
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions.
    Luo J, Zhao X, Tan Z, Su Z, Meng F, Zhang M.
    Cytotherapy; 2013 Jun; 15(6):649-62. PubMed ID: 23415919
    [Abstract] [Full Text] [Related]

  • 14. Rationale of mesenchymal stem cell therapy in kidney injury.
    Cantaluppi V, Biancone L, Quercia A, Deregibus MC, Segoloni G, Camussi G.
    Am J Kidney Dis; 2013 Feb; 61(2):300-9. PubMed ID: 22938846
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms.
    Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C.
    Am J Physiol Renal Physiol; 2005 Jul; 289(1):F31-42. PubMed ID: 15713913
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.